629P Phase I study of pamiparib and cabozantinib in patients with metastatic solid tumors harboring homologous recombination deficiency (HRD)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.696
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
17
Citations
1
h-index
1
i10-index
E.E. Dumbrava is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & PARP inhibition in cancer therapy. The author has an h-index of 1, co-authored 6 publications.
Click to start Chat